Cite
MLA Citation
Stanley B Cohen et al.. “Similar efficacy, safety and immunogenicity of adalimumab biosimilar BI 695501 and Humira reference product in patients with moderately to severely active rheumatoid arthritis: results from the phase III randomised VOLTAIRE-RA equivalence study.” Annals of the rheumatic diseases, vol. 77, no. 6, 2018, pp. 914–921. http://access.bl.uk/ark:/81055/vdc_100150407604.0x00005c